 Opko Health NASDAQ:OPKs stock had its buy rating reiterated by research analysts at Piper Sandler in a research report issued on Friday, TipRanks reports. Piper Sandler also issued estimates for Opko Healths Q1 2021 earnings at 0.11 EPS and FY2021 earnings at 0.40 EPS. Several other research analysts also recently commented on the company. Piper ... 